|
|
|
| Clinical Effect of Tirofiban Combined with Clopidogrel on Acute Myocardial Infarction and the Levels of IL-6, TNF-α and hs-CRP in Serum |
| ZHANG Ming, HOU Jianwei, WANG Xihui, et al |
| The Second Affiliated Hospital of Xi'an Medical University, Shaanxi Xi'an 710038, China |
|
|
|
|
Abstract Objective: To explore the clinic effect of tirofiban (TIR) combined with clopidogrel (CLO) on acute myocardial infarction (AMI) and the levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and high sensitivity C-reactive protein (hs-CRP) in serum. Methods: 119 cases of patients with AMI admitted in our hospital from January 2015 to January 2017 were selected as research objectives, and according to simple random method, those patients were divided into two groups. The observation group (60 cases) was treated by TIR combined with CLO, while the control group (59 cases) was treated by CLO. The clinical effect, changes of serum IL-6, TNF-α, hs-CRP levels before and after treatment as well as the incidence of adverse reactions were compared between two groups. Results: After treatment, the overall effective rate of observation group was 95.0%, which was significantly higher than that of the control group (81.4%, P<0.05). The serum IL-6, TNF-α, hs-CRP levels of both groups after treatment were significantly lower than those before treatment (P<0.01), and the serum IL-6, TNF-α, hs-CRP of the observation group were significantly lower the in the control group at same time (P<0.01). The total incidence of adverse reactions in the two groups was 6.7% and 5.1%, respectively, and there was no significant difference between the two groups. (P>0.05). Conclusion: Tirofiban combined with clopidogrel could effectively control the inflammation and improve the treatment effect with high safety.
|
|
|
|
|
|
[1] 黄震华.急性心肌梗死抗炎症治疗对心室重构的影响[J].中国新药与临床杂志,2015,34(10):738~743.
[2] 谢阳,林宇鹏,黄伟鹏.替罗非班治疗急性冠脉综合征的有效性及安全性[J].中国循证心血管医学杂志,2015,7(3):368~370.
[3] 刘建峰,朱莹,王晓玮,等.国产替罗非班对中国人群非ST段抬高急性冠脉综合征有效性与安全性的Meta分析[J].中国循证医学杂志,2015,15(1):90~98.
[4] 李秀芬,葛振嵘,许力舒,等.替格瑞洛联合小剂量替罗非班对急性非ST段抬高心肌梗死患者纤维蛋白原的影响[J].中华老年心脑血管病杂志,2015,17(4):429~430.
[5] 郑时康,任晖.替罗非班对急性心肌梗死的疗效及对炎性因子和心功能的影响[J].医学综述,2016,22(10):2012~2015. |
|
|
|
2018, Vol. 24 
